In a context of economic contraction and disinvestment in certain sectors, D&M Pharma has adopted a counter-cyclical strategy focused on growth and job creation. In December 2023, the company announced an ambitious expansion plan: it was preparing and training new sales representatives, adding positions, and creating employment in its Cassará Division.
Their stated mission emphasizes providing safe, effective, and accessible medications backed by international expertise and social responsibility.
Integration of biotechnology into their medicinal development, particularly through the Cassará division. Regulatory Compliance & Quality Standards
is a pharmaceutical wholesale and distribution company based in Lima, Peru. Established in 2007 , the company operates as a key regional partner for international laboratories, most notably the Argentine firm Laboratorio Cassará . Company Overview d amp m pharma peru sac
The company was officially incorporated on August 1, 2007 .
is a highly specialized pharmaceutical enterprise headquartered in Lima, Peru, that serves as a vital bridge for international manufacturing and medical solutions within the Latin American Pacific market . Founded locally in August 2007, the company acts as a strategic distribution, commercialization, and marketing hub. It operates within the highly competitive merchant wholesale sector for nondurable and healthcare goods.
comparing them to other Peruvian labs like Roxfarma or Medifarma. A deeper look into their regulatory compliance history with DIGEMID. A detailed product list breakdown for one of their specific divisions (e.g., Dermatology). D & M Pharma Peru S.A.C. Company Profile - EMIS In a context of economic contraction and disinvestment
A common aerosol inhaler for relief of bronchospasms.
Established as an international expansion branch of the broader Chilean corporate entity, the company serves as a vital bridge in the South American pharmaceutical supply chain. By collaborating with esteemed global laboratories—most notably Argentina's Laboratorio Cassará —the firm ensures the Peruvian population has access to high-quality therapeutic respiratory, ophthalmic, and skincare options. Corporate History and Regional Expansion
Focusing on high-volume medications such as antibiotics, antihypertensives, and antidiabetics, the company leverages Peru’s growing demand for affordable yet high-quality generics. They often partner with Indian, Chinese, and Colombian active pharmaceutical ingredient (API) manufacturers. Company Overview The company was officially incorporated on
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later. D & M Pharma Peru S.A.C. Company Profile - EMIS
In the rapidly evolving landscape of the Peruvian pharmaceutical industry, few names have garnered as much attention among healthcare professionals and distributors as . As a specialized entity operating within one of South America’s most dynamic healthcare markets, this company represents a critical link in the supply chain of medicines, medical devices, and pharmaceutical services.
: The company works closely with international partners like Laboratorio Cassará
The company continues to hold a significant voice in the Peruvian health sector. Notably, in April 2026 , the company's Technical Director, Dra. Mery Luz Peña García
As of late 2024, the enterprise operates with a team of approximately 32 employees out of its headquarters in San Isidro, Lima Therapeutic Specializations